After a buoyant week, investors are expected to start the week with caution. With a lack of overarching global cues, volatility may persist. The rising number of cases of Covid in China and citizens retaliating against the Zero-Covid policy will be a topic that investors will keep an eye on.

Zydus Lifesciences has received approval from the United States Food and Drug Administration (USFDA) to market Levothyroxine Sodium injection, used to treat thyroid hormone deficiency. The company’s US-based unit has received tentative approval from the US Food and Drug Administration (USFDA) to market the medication, the drug firm said in a regulatory filing.

Zydus Lifesciences Limited’s (formerly known as Cadila Healthcare Limited) U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the United States Food and Drug Administration (USFDA) to market Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial,” Zydus Lifesciences said in a regulatory filingFitch Ratings on Monday said India’s bank credit will see strong growth in current financial year despite effects of higher interest rates.

It said the strong loan growth should benefit net revenue, particularly as it will be coupled with wider net interest marginsWe see bank credit expanding by around 13 per cent in FY23, up from 11.5 per cent in FY22. The acceleration will be driven by the normalisation of economic activity after the COVID-19 pandemic, and high nominal GDP growth, which we expect to boost demand for retail and working-capital loans,” Fitch said in a statement.

Fitch forecasts India’s real GDP growth at 7 per cent in 2022-23. It said Indian banks generally remain open to additional capital-raising to fund growth, despite the rise in rates. (PTI)Taiwan stocks dropped on Monday, weighed by ruling party DPP’s resounding defeat in local elections and amid a broader selloff across Asia.

The benchmark Taiex slid 1.5%, the most since Oct. 13, as investors worried that the government may stop support measures for the market after opposition Kuomintang’s victory at the polls. The party, which favors eventual unification with China, held onto 13 seats at Saturday’s elections.The riskoff sentiment in Taiwan was in line with a wider decline across the region as protests against China’s Covid restrictions over the weekend prompted traders to re-think investment plans after jumping back in on reopening hopes.

Results of the local elections may only impact markets for a day, according to Li Fang-kuo, chairman at President Capital Management in Taipei. Further out, “we are still positive on the outlook of stocks as Taiex usually rises in December.” (Bloomberg)

Gold prices in India dipped today while silver plunged, tracking a similar global trend as covid protests in China dampened global risk sentiment. Gold futures on MCX fell 0.25% to ₹52,420 per 10 gram, extending losses to the second day. Silver fell 0.8% to ₹61,185 per kg. Other commodities including metals and crude dropped today as unrest in China dampened demand outlook.

Protests in China have dampened global risk sentiment, according to analysts. “Risk off moves are seen across asset classes this Monday morning in Asia session. The dollar has strengthened across the board, especially against commodity currencies,” IFA Global said in a note. (The benchmark Nikkei 225 index eased 0.42%, or 120.20 points, to 28,162.83, while the broader Topix index fell 0.68%, or 13.69 points, to 2,004.31. (AFP)